“Johnson & Johnson announced a voluntary agreement with the Trump Administration on drug pricing aimed at improving access to medicines and lowering costs for millions of American patients.1 The agreement, which meets President Trump’s requests to the pharmaceutical industry, also provides the company’s products with an exemption from tariffs.”
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump’s Drug-Pricing Effort | AJMC